|
Recent Developments |
|
31-JUL-13
Piramal Life Sciences said its net loss for the quarter ended June 2013 has widened to Rs 15.60. It reported a net loss of Rs 15.40 million in the same quarter last year.
08-MAY-13
Piramal Life Sciences fourth-quarter net loss narrows to Rs 9.7 million for the quarter ended Mar. 31, 2013 as compared to Rs 55.2 million a year ago
01-FEB-13
Piramal Life Sciences offer proprietary medicinal products that are made from standardized herb... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2015(9) | 31-Mar-2015(12) | 31-Mar-2014 (12) | | Net sales | 55.30 | 45.40 | 59.60 | | Other Income | 1.50 | 3.80 | 2.20 | | Total Income | 56.80 | 49.20 | 61.80 | | Cost of goods sold | 40.10 | 37.40 | 58.00 | | OPBDIT | 16.70 | 11.80 | 3.80 | | PAT | -18.00 | -34.60 | -42.30 | | Gross Block | - | - | - | | Equity capital | 259.60 | 259.60 | 259.60 | | EPS (Rs.) | - | - | -1.60 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 29.4 | 24.0 | 6.1 | | Net margin (% of OI) | -31.7 | -70.3 | -68.4 |
|
|
Detailed Financials
|
|
|
|
|
